QT
ABEO icon

Quantamental Technologies’s Abeona Therapeutics ABEO Stock Holding History

Quantamental Technologies’s Portfolio ABEO Stock Details ABEO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q1 		– Sell
-64
Closed -$11K – 1432
2018
Q4 		$11K Buy
+64
New +$14K 0.01% 1129

Other funds holding ABEO

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
KCM
Knoll Capital Management Miami, Florida $180M AUM 66.11% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
RPAM
Rhenman & Partners Asset Management Stockholm, Sweden $810M AUM 30.2% 1-Year Est. Return

Quantamental Technologies's ABEO Position: Q1 2019 in Review

Quantamental Technologies sold out of Abeona Therapeutics (ABEO) in Q1 2019, closing a stake of 64 shares — an estimated $11K sold.

Quantamental Technologies first reported a position in ABEO in Q4 2018 and held it in 1 quarter. The position peaked at $11K in Q4 2018. 87 funds tracked by Wall St. Rank hold ABEO as of Q1 2019.

  • Quantamental Technologies reported no remaining Abeona Therapeutics position as of Q1 2019 after selling out during the quarter.
  • Quantamental Technologies sold 64 Abeona Therapeutics shares in Q1 2019, an estimated $11K.
  • Quantamental Technologies first reported a position in Abeona Therapeutics in Q4 2018 and held it in 1 quarter.
  • Quantamental Technologies's Abeona Therapeutics position peaked at $11K in Q4 2018.
  • 87 funds tracked by Wall St. Rank held Abeona Therapeutics as of Q1 2019.

Based on Quantamental Technologies's 13F filing for Q1 2019, filed 29 Apr 2019.